​

STAAR Surgical Company (STAA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

STAAR Surgical Company Revenue Highlights

Latest Revenue (Y)

$322.42K

Latest Revenue (Q)

$88.59M

Main Segment (Y)

Implantable Collamer Lenses

Main Geography (Y)

Other Countries

STAAR Surgical Company Revenue by Period

STAAR Surgical Company Revenue by Year

DateRevenueChange
2023-12-29$322.42K-99.89%
2022-12-30$284.39M23.40%
2021-12-31$230.47M41.00%
2021-01-01$163.46M8.84%
2020-01-03$150.19M21.16%
2018-12-28$123.95M36.80%
2017-12-29$90.61M9.92%
2016-12-30$82.43M6.88%
2016-01-01$77.12M2.85%
2015-01-02$74.99M3.84%
2014-01-03$72.22M13.22%
2012-12-28$63.78M1.62%
2011-12-30$62.77M14.21%
2010-12-31$54.96M-27.06%
2010-01-01$75.34M0.60%
2009-01-02$74.89M26.16%
2007-12-28$59.36M5.47%
2006-12-29$56.28M9.71%
2005-12-30$51.30M-0.74%
2004-12-31$51.69M2.43%
2004-01-02$50.46M4.58%
2003-01-03$48.25M-3.96%
2001-12-28$50.24M-6.94%
2000-12-29$53.99M-8.50%
1999-12-31$59.00M8.86%
1999-01-01$54.20M27.53%
1998-01-02$42.50M0.71%
1997-01-03$42.20M21.61%
1995-12-29$34.70M26.64%
1994-12-31$27.40M36.32%
1993-12-31$20.10M-

STAAR Surgical Company generated $322.42K in revenue during NA 2023, up -99.89% compared to the previous quarter, and up 0.26% compared to the same period a year ago.

STAAR Surgical Company Revenue by Quarter

DateRevenueChange
2024-09-27$88.59M-10.52%
2024-06-28$99.00M27.99%
2024-03-29$77.36M1.42%
2023-12-29$76.27M-5.02%
2023-09-29$80.31M-13.00%
2023-06-30$92.31M25.54%
2023-03-31$73.53M14.81%
2022-12-30$64.04M-15.78%
2022-09-30$76.05M-6.23%
2022-07-01$81.10M28.32%
2022-04-01$63.20M7.12%
2021-12-31$59.00M1.11%
2021-10-01$58.35M-6.44%
2021-07-02$62.37M22.89%
2021-04-02$50.75M10.34%
2021-01-01$46.00M-2.30%
2020-10-02$47.08M33.78%
2020-07-03$35.19M0.02%
2020-04-03$35.19M-9.51%
2020-01-03$38.88M-0.44%
2019-09-27$39.05M-1.54%
2019-06-28$39.66M21.73%
2019-03-29$32.58M4.48%
2018-12-28$31.19M-1.84%
2018-09-28$31.77M-6.30%
2018-06-29$33.91M25.14%
2018-03-30$27.09M9.02%
2017-12-29$24.85M5.87%
2017-09-29$23.47M7.01%
2017-06-30$21.94M7.79%
2017-03-31$20.35M-8.07%
2016-12-30$22.14M10.40%
2016-09-30$20.05M-4.40%
2016-07-01$20.97M8.85%
2016-04-01$19.27M2.77%
2015-10-02$18.75M0.50%
2015-07-03$18.66M-1.07%
2015-04-03$18.86M13.79%
2015-01-02$16.57M-8.88%
2014-10-03$18.19M-9.28%
2014-07-04$20.05M-0.64%
2014-04-04$20.18M6.51%
2014-01-03$18.94M10.74%
2013-09-27$17.11M-5.82%
2013-06-28$18.16M0.91%
2013-03-29$18.00M9.32%
2012-12-28$16.47M3.79%
2012-09-28$15.87M-0.48%
2012-06-29$15.94M2.79%
2012-03-30$15.51M-5.32%
2011-12-30$16.38M7.30%
2011-09-30$15.27M-6.17%
2011-07-01$16.27M9.56%
2011-04-01$14.85M3.20%
2010-12-31$14.39M9.41%
2010-10-01$13.15M-3.57%
2010-07-02$13.64M-1.01%
2010-04-02$13.78M-30.52%
2010-01-01$19.83M9.48%
2009-10-02$18.11M-5.25%
2009-07-03$19.12M4.56%
2009-04-03$18.28M0.69%
2009-01-02$18.16M0.25%
2008-09-26$18.11M-12.35%
2008-06-27$20.66M15.06%
2008-03-28$17.96M13.06%
2007-12-28$15.88M-

STAAR Surgical Company generated $88.59M in revenue during Q3 2024, up -10.52% compared to the previous quarter, and up 95.97% compared to the same period a year ago.

STAAR Surgical Company Revenue Breakdown

STAAR Surgical Company Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Jan 21Jan 20Dec 18
Implantable Collamer Lenses$269.71M$212.91M$141.41M$129.32M$101.08M
Cataract Intraocular Lenses$9.64M$12.52M---
Other Surgical Products$5.04M$5.05M$8.48M$5.17M$6.68M
Intraocular Lenses--$13.57M$15.69M$16.19M

STAAR Surgical Company's latest annual revenue breakdown by segment (product or service), as of Dec 22: Implantable Collamer Lenses (94.84%), Cataract Intraocular Lenses (3.39%), and Other Surgical Products (1.77%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Apr 22Oct 21Jul 21Apr 21Jan 21Oct 20Jul 20Apr 20Jan 20Sep 19Jun 19
Implantable Collamer Lenses$89.10M$77.15M$319.43M$81.07M$93.11M$70.63M$61.16M$71.95M$77.92M$58.67M$54.15M$59.23M$46.50M$39.85M$41.49M$30.73M$29.34M$33.29M$33.81M$34.43M
Other Surgical Products-$205.00K$1.85M$-540.00K$-846.00K$1.43M$884.00K$1.90M$632.00K$1.62M$1.67M$58.00K$526.00K$2.46M$2.26M$1.91M$1.85M$1.89M$1.15M$1.36M
Cataract Intraocular Lenses--$1.14M$221.00K$40.00K$1.48M$2.00M$2.19M$2.55M$2.90M$2.52M---------
Intraocular Lenses-----------$3.07M$3.73M$3.69M$3.33M$2.56M$3.99M$3.71M$4.09M$3.87M

STAAR Surgical Company's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Implantable Collamer Lenses (100.00%).

STAAR Surgical Company Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 18
Other Countries$47.42M
CHINA$46.07M
JAPAN$23.15M
UNITED STATES$7.32M

STAAR Surgical Company's latest annual revenue breakdown by geography, as of Dec 18: Other Countries (38.25%), CHINA (37.17%), JAPAN (18.68%), and UNITED STATES (5.90%).

Quarterly Revenue by Country

CountrySep 19Jun 19Mar 19Dec 18Sep 18Jun 18Mar 18
JAPAN$7.34M$6.28M$5.52M$5.37M$6.01M$6.69M$5.08M
Other Countries$13.35M$13.99M$12.00M$7.65M$12.41M$13.25M$10.15M
CHINA$18.36M$19.39M$11.77M$10.85M$13.35M$13.96M$7.91M
KOREA, REPUBLIC OF--$3.29M$2.19M---
UNITED STATES------$1.76M

STAAR Surgical Company's latest quarterly revenue breakdown by geography, as of Sep 19: CHINA (47.01%), Other Countries (34.18%), and JAPAN (18.81%).

STAAR Surgical Company Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BDXBecton, Dickinson and Company$20.18B$4.99B
RMDResMed$4.69B$1.22B
HOLXHologic$4.03B$1.01B
COOCooper Companies$3.90B$1.00B
ATRAptarGroup$3.49B$909.29M
WSTWest Pharmaceutical Services$2.95B$746.90M
NVSTEnvista$2.57B$884.70M
ICUIICU Medical$2.26B$589.13M
HAEHaemonetics$1.31B$336.17M
MMSIMerit Medical Systems$1.26B$339.85M
RGENRepligen$638.76M$141.19M
ANGOAngioDynamics$303.91M$67.49M
STAASTAAR Surgical Company$322.42K$88.59M
MBOTMicrobot Medical--

STAA Revenue FAQ

What is STAAR Surgical Company’s yearly revenue?

STAAR Surgical Company's yearly revenue for 2023 was $322.42K, representing a decrease of -99.89% compared to 2022. The company's yearly revenue for 2022 was $284.39M, representing an increase of 23.40% compared to 2021. STAA's yearly revenue for 2021 was $230.47M, representing an increase of 41.00% compared to 2020.

What is STAAR Surgical Company’s quarterly revenue?

STAAR Surgical Company's quarterly revenue for Q3 2024 was $88.59M, a -10.52% decrease from the previous quarter (Q2 2024), and a 10.31% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $99M, a 27.99% increase from the previous quarter (Q1 2024), and a 7.26% increase year-over-year (Q2 2023). STAA's quarterly revenue for Q1 2024 was $77.36M, a 1.42% increase from the previous quarter (Q4 2023), and a 5.21% increase year-over-year (Q1 2023).

What is STAAR Surgical Company’s revenue growth rate?

STAAR Surgical Company's revenue growth rate for the last 3 years (2021-2023) was -99.86%, and for the last 5 years (2019-2023) was -99.79%.

What are STAAR Surgical Company’s revenue streams?

STAAR Surgical Company's revenue streams in c 22 are Implantable Collamer Lenses, Cataract Intraocular Lenses, and Other Surgical Products. Implantable Collamer Lenses generated $269.71M in revenue, accounting 94.84% of the company's total revenue, up 26.68% year-over-year. Cataract Intraocular Lenses generated $9.64M in revenue, accounting 3.39% of the company's total revenue, down -23.01% year-over-year. Other Surgical Products generated $5.04M in revenue, accounting 1.77% of the company's total revenue, down -0.14% year-over-year.

What is STAAR Surgical Company’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of STAAR Surgical Company was Implantable Collamer Lenses. This segment made a revenue of $269.71M, representing 94.84% of the company's total revenue.